Engineering of a microbial coculture of Escherichia coli strains for the biosynthesis of resveratrol

Microbial Cell Factories

Volumn 15, Issue 1, 2016, Pages

  Camacho Zaragoza, José M ^a   Hernández Chávez, Georgina ^a   Moreno Avitia, Fabian ^a   Ramírez Iñiguez, René ^a   Martínez, Alfredo ^a   Bolívar, Francisco ^a   Gosset, Guillermo ^a  

^a INSTITUTO DE BIOTECNOLOGÍA   (Mexico)

Author keywords

Escherichia coli; Glycerol; Metabolic engineering; Microbial coculture; Resveratrol

Indexed keywords

GLYCEROL; PARA COUMARIC ACID; RESVERATROL; TRANSKETOLASE;

3 DEOXY DEXTRO ARABINO HEPTULOSONATE 7 PHOSPHATE SYNTHASE GENE; 4 COUMAROYL COENZYME A LIGASE GENE; ARTICLE; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM MUTANT; BIOENGINEERING; CARBON SOURCE; COCULTURE; CULTURE MEDIUM; DRUG SYNTHESIS; ESCHERICHIA COLI; GENE; GENE INACTIVATION; GENE OVEREXPRESSION; GRAPE; NONHUMAN; PEANUT; PHEA GENE; RHODOTHORULA GLUTINIS; STILBENE SYNTHASE GENE; STREPTOMYCES COELICOLOR; TRANSKETOLASE GENE; TYROSINE AMMONIA LYASE GENE; YEAST;

EID: 84988955364     PISSN: None     EISSN: 14752859     Source Type: Journal    
DOI: 10.1186/s12934-016-0562-z     Document Type: Article

References (33)

1. Renaud S, De Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet. 1992;339:1523-6.
2. Bradamante S, Barenghi L, Villa A. Cardiovascular protective effects of resveratrol. Cardiovasc Drug Rev. 2004;22:169-88.
3. Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y. Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies. Anticancer Res. 2004;24:2783-840.
4. Joe AK, Liu H, Suzui M, Vural ME, Xiao D, Weinstein IB. Resveratrol induces growth inhibition, S-phase arrest, apoptosis, and changes in biomarker expression in several human cancer cell lines. Clin Cancer Res. 2002;8:893-903.
5. Jeandet P, Delaunois B, Aziz A, Donnez D, Vasserot Y, Cordelier S, et al. Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol. J Biomed Biotechnol. 2012.
6. Docherty JJ, Fu MM, Tsai M. Resveratrol selectively inhibits Neisseria gonorrhoeae and Neisseria meningitidis. J Antimicrob Chemother. 2001;47:243-4.
7. Su H-C, Hung L-M, Chen J-K. Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Metab. 2006;290:E1339-46.
8. Watts KT, Lee PC, Schmidt-Dannert C. Biosynthesis of plant-specific stilbene polyketides in metabolically engineered Escherichia coli. BMC Biotechnol. 2006;6:22.
9. Wu J, Liu P, Fan Y, Bao H, Du G, Zhou J, et al. Multivariate modular metabolic engineering of Escherichia coli to produce resveratrol from l-tyrosine. J Biotechnol. 2013;167:404-11.
10. Jeandet P, Vasserot Y, Chastang T, Courot E. Engineering microbial cells for the biosynthesis of natural compounds of pharmaceutical significance. Biomed Res Int. 2013;2013:780145.
11. Leonard E, Yan Y, Fowler ZL, Li Z, Lim CG, Lim KH, et al. Strain improvement of recombinant Escherichia coli for efficient production of plant flavonoids. Mol Pharm. 2008;5:257-65.
12. Santos CNS, Koffas M, Stephanopoulos G. Optimization of a heterologous pathway for the production of flavonoids from glucose. Metab Eng Elsevier. 2011;13:392-400.
13. Lim CG, Fowler ZL, Hueller T, Schaffer S, Koffas MAG. High-yield resveratrol production in engineered Escherichia coli. Appl Environ Microbiol. 2011;77:3451-60.
14. Zecchin A, Stapor PC, Goveia J, Carmeliet P. Metabolic pathway compartmentalization: an underappreciated opportunity? Curr Opin Biotechnol. 2015;34:73-81.
15. Avalos JL, Fink GR, Stephanopoulos G. Compartmentalization of metabolic pathways in yeast mitochondria improves the production of branched-chain alcohols. Nat Biotechnol. 2013;31:335-41.
16. Zhang H, Pereira B, Li Z, Stephanopoulos G. Engineering Escherichia coli coculture systems for the production of biochemical products. Proc Natl Acad Sci. 2015;112:8266-71.
17. Zhang H, Li Z, Pereira B, Stephanopoulos G. Engineering E. coli-E. coli cocultures for production of muconic acid from glycerol. Microb Cell Fact. 2015;14:134.
18. Jones JA, Vernacchio VR, Sinkoe AL, Collins SM, Ibrahim MHA, Lachance DM, et al. Experimental and computational optimization of an Escherichia coli co-culture for the efficient production of flavonoids. Metab Eng. 2016;35:55-63.
19. Kaneko M, Ohnishi Y, Horinouchi S. Cinnamate: coenzyme A ligase from the filamentous bacterium Streptomyces coelicolor A3 (2). J Bacteriol. 2003;185:20-7.
20. Takamura Y, Nomura G. Changes in the intracellular concentration of acetyl-CoA and malonyl-CoA in relation to the carbon and energy metabolism of Escherichia coli K12. J Gen Microbiol. 1988;134:2249-53.
21. Vargas-Tah A, Martínez LM, Hernández-Chávez G, Rocha M, Martínez A, Bolívar F, et al. Production of cinnamic and p-hydroxycinnamic acid from sugar mixtures with engineered Escherichia coli. Microb Cell Fact. 2015;14:1-12.
22. Van Dyk TK, Templeton LJ, Cantera KA, Sharpe PL, Sariaslani FS. Characterization of the Escherichia coli AaeAB efflux pump: a metabolic relief valve? J Bacteriol. 2004;186:7196-204.
23. Sariaslani FS. Development of a combined biological and chemical process for production of industrial aromatics from renewable resources. Annu Rev Microbiol. 2007;61:51-69.
24. Li M, Kildegaard KR, Chen Y, Rodriguez A, Borodina I, Nielsen J. De novo production of resveratrol from glucose or ethanol by engineered Saccharomyces cerevisiae. Metab Eng. 2015;32:1-11.
25. Bachman BJ. Pedigrees of Some Mutant Strains of Escherichia coli K12. Bacteriol Rev. 1972;36:525-57.
26. Angov E, Hillier CJ, Kincaid RL, Lyon JA. Heterologous protein expression is enhanced by harmonizing the codon usage frequencies of the target gene with those of the expression host. PLoS One. 2008;3:1-10.
27. Fuhrmann M, Hausherr A, Ferbitz L, Schödl T, Heitzer M, Hegemann P. Monitoring dynamic expression of nuclear genes in Chlamydomonas reinhardtii by using a synthetic luciferase reporter gene. Plant Mol Biol. 2004;55:869-81.
28. Salis HM, Mirsky EA, Voigt CA. Automated design of synthetic ribosome binding sites to control protein expression. Nat Biotechnol. 2009;27:946-50.
29. Beekwilder J, Wolswinkel R, Jonker H, Hall R, De Vos CHR, Bovy A. Production of resveratrol in recombinant microorganisms. Appl Environ Microbioly. 2006;72:5670-2.
30. Huang L, Xue Z, Zhu Q. Method for the production of resveratrol in a recombinant bacterial host cell [Internet]. Google Patents; 2007. http://www.google.com.tr/patents/US20070031951.
31. Katsuyama Y, Funa N, Miyahisa I, Horinouchi S. Synthesis of unnatural flavonoids and stilbenes by exploiting the plant biosynthetic pathway in Escherichia coli. Chem Biol. 2007;14:613-21.
32. Amann E, Ochs B, Abel K-J. Tightly regulated tac promoter vectors useful for the expression of unfused and fused proteins in Escherichia coli. Gene. 1988;69:301-15.
33. Balderas-Hernández VE, Sabido-Ramos A, Silva P, Cabrera-Valladares N, Hernández-Chávez G, Báez-Viveros JL, et al. Metabolic engineering for improving anthranilate synthesis from glucose in Escherichia coli. Microb Cell Fact. 2009;8:19.